Scientists peek inside immune system to improve meningitis shots
NCT ID NCT01593514
First seen May 11, 2026 · Last updated May 15, 2026 · Updated 1 time
Summary
This study looked at how different meningitis vaccines affect specific white blood cells (B cells) in 20 healthy adults aged 30-70. Researchers compared older polysaccharide vaccines with newer conjugate vaccines to understand which vaccine triggers a stronger and longer-lasting immune response. The goal is to use this knowledge to design better vaccines that protect all age groups.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MENINGITIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Oxford Vaccine Group
Oxford, Oxfordshire, OX3 7LE, United Kingdom
Conditions
Explore the condition pages connected to this study.